Search

Search Constraints

You searched for: Author/Creator Feldman, Jeremy

Search Results

1. Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1). (May 2017)

2. FP804TWO-YEAR DURABILITY OF IMPROVEMENTS IN EGFR WITH BARDOXOLONE METHYL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: THE LARIAT STUDY. (28th May 2018)

4. An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil. (February 2021)

5. Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 1 (January 2022)

7. Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. (7th April 2022)

8. A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2). (11th May 2022)

9. Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation. (28th July 2022)

10. EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR. Issue 2 (25th February 2021)